Why 27.9% Cortisol Reduction Matters: Breaking Down the KSM-66 Ashwagandha RCT

Most supplement brands mention Ashwagandha and move on. We read the study.
Here is exactly what the clinical data shows — and why the difference between knowing a supplement “may help stress” and understanding the documented mechanism is everything.

The Study

In 2012, researchers Chandrasekhar, Kapoor, and Anishetty published a randomized, double-blind, placebo-controlled trial in the Indian Journal of Psychological Medicine. This is the gold standard of clinical research — the same methodology used to evaluate pharmaceutical drugs.

The study enrolled 64 adults with a documented history of chronic stress. Participants were randomly assigned to receive either 300mg of high-concentration full-spectrum Ashwagandha root extract (KSM-66) twice daily, or a placebo. Neither the participants nor the researchers knew who was taking what until the study concluded.

The trial ran for 60 days.

PubMed Reference: Chandrasekhar K, Kapoor J, Anishetty S. (2012). PubMed ID: 23439798

What Was Actually Measured

This is where most supplement marketing falls apart — they mention studies without telling you what was actually measured. Here is the complete list of outcomes measured in this trial:

Serum cortisol levels — a direct blood measurement of cortisol, the primary stress hormone produced by the adrenal glands. This is an objective biological marker, not a self-reported feeling.

Perceived Stress Scale (PSS) — a validated 10-item psychological instrument measuring the degree to which situations are appraised as stressful.

General Health Questionnaire-28 (GHQ-28) — a validated screening instrument measuring general psychological wellbeing across four subscales: somatic symptoms, anxiety, social dysfunction, and depression.

Depression Anxiety Stress Scale (DASS) — a 42-item self-report instrument measuring the severity of depression, anxiety, and stress symptoms.

The Results

After 60 days, the Ashwagandha group showed the following compared to placebo:
Serum cortisol: Reduced by 27.9% (p=0.0006 — statistically highly significant)
Perceived Stress Scale: Reduced by 44% from baseline

General Health Questionnaire-28: Reduced stress scores by 72.3%

Depression Anxiety Stress Scale: Reduced by 71.6%
Participants in the Ashwagandha group also reported significant improvements in sleep quality, mental calmness, concentration, and daily energy levels compared to the placebo group.

No serious adverse events were reported in either group.

Why 27.9% Matters

A 27.9% reduction in measured serum cortisol is not a marginal effect. Chronic cortisol elevation is associated with impaired immune function, disrupted sleep architecture, reduced testosterone in men, increased visceral fat storage, accelerated cognitive decline, and suppressed thyroid function.

This is not theoretical. These are documented physiological consequences of prolonged cortisol elevation in human populations.

A measurable reduction in serum cortisol — confirmed by blood test, not self-report — represents a real biological shift. Not a feeling. A measurement.
What KSM-66 Actually Is

KSM-66 is a branded, standardized root extract of Withania somnifera (Ashwagandha) standardized to a minimum of 5% withanolides — the bioactive compounds responsible for the adaptogenic effects.

Standardization matters because raw Ashwagandha powder varies widely in potency. KSM-66 guarantees a consistent concentration of the active compounds in every dose, which is why it is the extract used in the highest-quality clinical trials.

BioVitality Adapt contains 600mg of KSM-66 Ashwagandha per serving — confirmed on the Supplement Facts panel.

The BioVitality Cortisol Protocol

Standard supplement advice says take Ashwagandha once daily. The clinical data suggests a more nuanced approach.

The 60-day RCT used a split-dose protocol — 300mg twice daily. The athlete RCT published in Nutrients (2026) used 600mg once daily in a training context. The mechanistic literature on cortisol diurnal rhythm shows cortisol naturally peaks in the morning and declines throughout the day.

Based on this data, BioVitality recommends:
Training Days: Take BioVitality Adapt with breakfast — timing the dose to support cortisol modulation during exercise-induced stress peaks.

Recovery Days: Take BioVitality Adapt with dinner — supporting overnight cortisol 

normalization and sleep quality restoration.

This timed protocol is derived directly from the clinical trial data. No other brand is packaging this information this way.

The Bottom Line

A 60-day gold-standard clinical trial in 64 chronically stressed adults demonstrated that KSM-66 Ashwagandha at 300mg twice daily produced:
• 27.9% reduction in measured serum cortisol
• 44% reduction in perceived stress
• 72.3% reduction in general health stress scores
• 71.6% reduction on the Depression Anxiety Stress Scale
• Improved sleep, concentration, and energy
• Zero serious adverse events

This is what documented science looks like. This is the BioVitality standard.

Science References:
• Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine. 2012. PubMed ID: 23439798. Available at: pubmed.ncbi.nlm.nih.gov/23439798
• Krüger M, et al. Effects of KSM-66 Ashwagandha on cortisol in team sport athletes during pre-season training. Nutrients. January 2026. Available at: mdpi.com/2072-6643/18/2/230
• Pratte MA, et al. An Alternative Treatment for Anxiety: A Systematic Review of Human Trial Results Reported for the Ayurvedic Herb Ashwagandha. PMC. 2019. Available at: ncbi.nlm.nih.gov/pmc/articles/PMC6750292
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.